Lea is an Assistant Professor of Genome Sciences at the University of Washington and co-director of the Advanced Technology Lab at the Brotman Baty Institute for Precision Medicine. My goal is to eliminate VUS and to make genomic information more informative, equitable and impactful by delivering high quality functional data that have been systematically analyzed and packaged for rapid uptake to clinicians and industry. To achieve that goal, my research program has three main directions: 1) developing new multiplexed assays for variant effect (MAVE) technology to access to new and more informative phenotypes, 2) scaling existing MAVEs for broad application, and 3) breaking down barriers to the systematic application of functional data to clinical variant interpretation workflows.

Moderator: Katherine Crawford, MS, CGC
Clinical Science Liaison at Ambry Genetics
Katie is a Clinical Science Liaison at Ambry Genetics working with oncology, rare disease, and exome. She has previously worked clinically at Women & Infant's Hospital of Rhode Island for over five years as an oncology genetic counselor. She is a graduate of the Arcadia University Genetic Counseling Program and has numerous scientific publications in the fields of oncology, neurology, epidemiology, and psychiatry.
Educational Independence and Disclosure Policy
EducateNext is committed to providing independent, objective, and evidence-based educational content. None of the individuals in control of this content—including our planners, reviewers, and approval faculty—have any financial relationships with ineligible companies to disclose. For all educational sessions, speaker-specific disclosures regarding any potential conflicts of interest are required and will always be shared directly with learners at the beginning of their respective presentations.

Facebook
X
LinkedIn
Forward
